Anyaa Sachdev and Téa Shouldice of Half Hollow Hills High School East in Dix Hills were Long Island’s sole first-place ...

Media Capital Technologies (MCT) and The Horror Section will fully finance and produce “Ice Cream Man,” Eli Roth’s new horror film. Roth, a master of the genre whose work includes the ...

Predeceased by his parents, Julius and Ethel Simon; sister, Dorothy “Dottie ... and Aviva; great-grandson Eli; brother-in-law Eugene Salesin. Uncle to many nieces and nephews.

Belichick's new memoir comes out on May 6 via Simon & Schuster Natasha Dye is a writer-reporter for PEOPLE covering sports. Her previous work appears in The New York Post and Popstar! Magazine.

Firey quarterback Diego Pavia led the Commodores throughout the season, but he leaned on fellow New Mexico transfer Eli Stowers as his ... South Carolina's Joshua Simon and Ole Miss's Caden ...

Eli Lilly (LLY) has enjoyed a successful run the past several quarters as the company's blockbuster GLP-1 weight-loss drug Wegovy gains steam in the obesity space. Wegovy was first to market but ...

The last couple of quarters have been very favorable for Eli Lilly and Company (NYSE:LLY) and its position in the obesity and adjacent markets. The main competitor Novo Nordisk A/S (NVO ...

Pharmaceutical company Eli Lilly announced promising clinical trial results this week for a daily pill to treat obesity and diabetes. Besides the good news of minimal side effects and impressive ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced success Thursday of its Phase 3 clinical trial for a once-daily GLP-1 pill — an oral form of the blockbuster medication used for ...

Drugmaker Eli Lilly announced promising Phase 3 study results for its new GLP-1 pill. Orforglipron is a drug similar to Ozempic but without the injection, making it more accessible. The pill ...

Eli Lilly stock surged as much as 17% after positive phase-three trial data came out for orforglipron. It found orforglipron, a GLP-1 weight-loss pill, led to significant weight and A1C reductions ...

Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets, valued at more than $100 billion. Each of them has advantages, as well as dark spots in the pipeline of ...